Friday, February 05, 2016 7:35:38 PM
Bill claimed in May of 2014 the interior was complete, finished, pharma grade (he turned down an offer by the Globe and Mail to show the interior of the building citing rules and regulations when in fact numerous other companies had done exactly that with no repercussions) but the town building supervisor was quoted by a council member in September of 2014 both buildings were non-operational, basically empty shells which of course, flies directly in the face of Bill's claim. Bill will now be required to prove to the court his building was complete and was ready to produce when given a license by Health Canada - if he cannot prove the building was completed as he claimed it was, then there might be an issue. There is the possibility that Health Canada then, once they win this case, and they will, will ask for legal expenses to be paid to them by CEN Biotech. But let's not get ahead of ourselves. Take the one property CEN owns, paid $1.2 million for it. Divide that by how billion shares and that is how much each shareholder would receive as an asset EXCEPT only preferred shares are entitled to asset claims for the winding up of a corporation after secured creditors are paid (Bill for example) so he would likely receive the proceeds from the sale of that former horse surgery not investors. After all the secured creditors are paid, then preferred shareholders and after that, if anything left, common shareholders. Common shareholders do get a vote. When was the last annual shareholders meeting held? You will get to have a CEN Biotech shareholders meeting once you get your fee shares however, unless Bill applies to the court to delay the shareholders meeting. He was the only director of record for CEN Biotech I or II. There are two different companies, each with Bill as the only director.
It is made of paper. Except Bills paper is money, yours is worthless share certificates.
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM